Skip to main content
FLUENCE CORPORATION LIMITED logo

FLUENCE CORPORATION LIMITED — Investor Relations & Filings

Ticker · FLC ISIN · AU000000FLC5 LEI · 529900W0WS96MODKXL22 ASX Water supply; sewerage, waste management and remediation activities
Filings indexed 951 across all filing types
Latest filing 2026-05-11 Regulatory Filings
Country AU Australia
Listing ASX FLC

About FLUENCE CORPORATION LIMITED

https://www.fluencecorp.com

Fluence Corporation Limited specializes in decentralized water, wastewater, and reuse solutions. The company provides pre-engineered, modular treatment systems designed for rapid deployment and high energy efficiency. Its core technology portfolio includes the Membrane Aerated Biofilm Reactor (MABR), marketed under the Aspiral and SUBRE brands, which offers advanced nutrient removal with low energy consumption. Additionally, the company provides NIROBOX, a modular solution for seawater and brackish water desalination and process water treatment. Fluence serves municipal, industrial, and commercial clients globally, focusing on sustainable water management through decentralized infrastructure that reduces the need for extensive piping and centralized facilities. Its solutions are characterized by their scalability, automated operation, and small physical footprint.

Recent filings

Filing Released Lang Actions
FLC Wins Strategic $3.7M Industrial Water Contract in US 2 pages 250.8KB
Regulatory Filings Classification · 75% confidence The document is a corporate press release announcing Fluence Corporation’s award of a USD $3.7 million industrial water treatment contract in Texas. It contains project details, CEO commentary, and contact information, but no financial results, governance disclosures, or regulatory filings of the types defined (e.g., annual report, earnings release, management change, dividend notice). It does not fit any specific category such as M&A, CAP, IR, ER, or DIV. As a general corporate announcement that does not match other categories, it falls into the fallback category for miscellaneous filings: Regulatory Filings (RNS).
2026-05-11 English
Investor Presentation 23 pages 2.7MB
Regulatory Filings
2026-05-07 English
Application for quotation of securities - FLC 9 pages 24.2KB
Share Issue/Capital Change Classification · 100% confidence The document is an Appendix 2A form, which is an application for quotation of securities on the ASX. It details the issuance of new securities under an employee incentive scheme, including the number of securities, issue date, and related information. This type of document is a formal announcement related to share issuance and capital changes, specifically the listing or quotation of new shares. It is not a financial report, earnings release, or management discussion. The content aligns with announcements about share issues or capital changes rather than other categories like annual reports or regulatory filings. Therefore, the appropriate classification is Share Issue/Capital Change (SHA).
2026-05-05 English
Cleansing Notice 1
Regulatory Filings Classification · 95% confidence The document is a notice under section 708A(5)(e) of the Corporations Act 2001 (Cth) regarding the issuance of shares to Non-Executive Directors in lieu of accrued director fees. It is a regulatory announcement about a share issuance event without disclosure under Part 6D.2 of the Corporations Act. The document is short (2587 characters) and primarily serves as a formal notification rather than a detailed financial report or analysis. It does not contain financial statements, management discussion, or detailed financial data. It is not an annual or interim report, earnings release, or capital/financing update in the traditional sense but a regulatory compliance notice. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2026-05-05 English
Change of Director's Interest Notices x 4 14 pages 560.8KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director's Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in directors' relevant interests in securities, including direct and indirect holdings, dates of changes, number of securities held before and after changes, and the nature of the changes (e.g., issue of shares in lieu of accrued fees). The document is a formal notification of personal share transactions by company directors. It does not contain financial performance data, earnings, or management discussion, nor is it an announcement of a report publication. Therefore, it fits the category of Director's Dealing filings, which report personal share transactions by company directors and executives (insider trades).
2026-05-05 English
Appendix 4C - Quarterly 5 pages 306.4KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Appendix 4C Quarterly cash flow report for entities subject to Listing Rule 4.7B' and contains detailed quarterly cash flow statements including operating, investing, and financing activities for the quarter ended 31 March 2026. It includes actual financial data such as receipts, payments, cash balances, financing facilities, and management commentary on liquidity and funding. The document is approximately 11,917 characters long, indicating it is a substantive report rather than a brief announcement. The content aligns with a quarterly financial report providing comprehensive financial data for a period shorter than a full fiscal year. Therefore, this document fits the definition of an Interim / Quarterly Report (IR).
2026-04-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.